#ASCO 2017 Survival profile in breast cancer molecular subtypes without systemic and locoregional treatment Gerar link Facebook Twitter Pinterest E-mail Outros aplicativos junho 30, 2017 Leia mais
#ASC0 2017 Hormone replacement therapy (HRT) among BRCA mutation carriers Gerar link Facebook Twitter Pinterest E-mail Outros aplicativos junho 30, 2017 Leia mais
#ASCO 2017 Risk of breast or ovarian cancer in family members who do not carry the BRCA1 or BRCA2 family mutation: Findings from the EMBRACE study Gerar link Facebook Twitter Pinterest E-mail Outros aplicativos junho 30, 2017 Leia mais
#ASCO2017 Association of baseline plasma levels of 25OH vitamin D and breast cancer risk in a chemoprevention trial. Gerar link Facebook Twitter Pinterest E-mail Outros aplicativos junho 30, 2017 Leia mais
#ASCO2017 Alectinib Versus Crizotinib in Treatment-Naive Advanced ALK Positive Non-Small Cell Lung Cancer (NSCLC): Primary Results of the Global Phase III ALEX Study Gerar link Facebook Twitter Pinterest E-mail Outros aplicativos junho 30, 2017 Leia mais
#ASCO2017 Impact of consensus molecular subtyping (CMS) on overall survival (OS) and progression free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance). Gerar link Facebook Twitter Pinterest E-mail Outros aplicativos junho 27, 2017 Leia mais
#ASCO2017 Progression After the Next Line of Therapy (PFS2) and Updated OS Among Patients with Advanced NSCLC and PD-L1 TPS >=50% enrolled in KEYNOTE-024 Gerar link Facebook Twitter Pinterest E-mail Outros aplicativos junho 27, 2017 Leia mais
#ASCO2017 Consensus Molecular Subgroups (CMS) of Colorectal Cancer (CRC) and 1st Line Efficacy of FOLFIRI Plus Cetuximab or Bevacizumab: Analysis of the FIRE-3 (AIO KRK 0306) Study Gerar link Facebook Twitter Pinterest E-mail Outros aplicativos junho 27, 2017 Leia mais
